Skip to search.
 TSX Up 0.74% TSX Ventures Up 0.24%

Biogen Inc. (BIIB)

-NasdaqGS
285.30 Down 5.86(2.01%) Dec 7, 4:00PM EST
Prev Close:291.16
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:339.98
Beta:0.327313
Earnings Date:Jan 25 - Jan 30 (Est.)
Day's Range:N/A - N/A
52wk Range:223.02 - 333.65
Volume:0
Avg Vol (3m):1,543,130
Market Cap:62.07B
P/E (ttm):16.14
EPS (ttm):17.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BIIBDown 2.01%62.07B
1 0.00%N/A
PFEDown 1.17%189.27B
ABTUp 0.16%56.65B

Key Statistics

Forward P/E (1 yr):13.69
P/S (ttm):5.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.20
Quarterly EPS Est (Dec-16) :4.99
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.62

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback